OYV
1 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Inherited Nucleotide Repeat Disorder Dna Test
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.5970
- Medical specialty
- Immunology
- FDA definition
- An inherited nucleotide repeat disorder DNA test is a prescription in vitro diagnostic test that is intended to detect and identify the number of nucleotide repeats in a gene using genomic DNA isolated from post-natal patient specimens. It is solely intended as an aid for carrier testing and as an aid for the diagnosis of inherited nucleotide repeat-associated disorders. Assay results are solely intended to be used in conjunction with other clinical and diagnostic findings. These tests do not include those indicated for use for fetal diagnostic testing or newborn screening.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| AmplideX Fragile X Dx & Carrier Screen Kit (DEN190023) | Asuragen, Inc. | 2020-02-21 |
Track OYV automatically
Every clearance here is in the API, with alerts when new ones post.